سامانه مدیریت نشریات علمی دانشگاه علوم پزشکی مشهد

Shanei, Ahmad, Sazgarnia, Ameneh, Hassanzadeh-Kayyat, Mohammad, Eshghi, Hossein, Soudmand, Samaneh, Attaran Kakhki, Neda. (1390). Evaluation of Sonochemiluminescence in a Phantom in the Presence of Protoporphyrin IX Conjugated to Nanoparticles. , 9(1), 41-50. doi: 10.22038/ijmp.2012.329
Ahmad Shanei; Ameneh Sazgarnia; Mohammad Hassanzadeh-Kayyat; Hossein Eshghi; Samaneh Soudmand; Neda Attaran Kakhki. "Evaluation of Sonochemiluminescence in a Phantom in the Presence of Protoporphyrin IX Conjugated to Nanoparticles". , 9, 1, 1390, 41-50. doi: 10.22038/ijmp.2012.329
Shanei, Ahmad, Sazgarnia, Ameneh, Hassanzadeh-Kayyat, Mohammad, Eshghi, Hossein, Soudmand, Samaneh, Attaran Kakhki, Neda. (1390). 'Evaluation of Sonochemiluminescence in a Phantom in the Presence of Protoporphyrin IX Conjugated to Nanoparticles', , 9(1), pp. 41-50. doi: 10.22038/ijmp.2012.329
Shanei, Ahmad, Sazgarnia, Ameneh, Hassanzadeh-Kayyat, Mohammad, Eshghi, Hossein, Soudmand, Samaneh, Attaran Kakhki, Neda. Evaluation of Sonochemiluminescence in a Phantom in the Presence of Protoporphyrin IX Conjugated to Nanoparticles. , 1390; 9(1): 41-50. doi: 10.22038/ijmp.2012.329

Evaluation of Sonochemiluminescence in a Phantom in the Presence of Protoporphyrin IX Conjugated to Nanoparticles

Iranian Journal of Medical Physics
مقاله 6، دوره 9، شماره 1، خرداد 2012، صفحه 41-50    اصل مقاله (962.26 K)
نوع مقاله: Original Paper
شناسه دیجیتال (DOI): 10.22038/ijmp.2012.329
نویسندگان
Ahmad Shanei1؛ Ameneh Sazgarnia* 2؛ Mohammad Hassanzadeh-Kayyat3؛ Hossein Eshghi4؛ Samaneh Soudmand5؛ Neda Attaran Kakhki4
1Medical Physics and Medical Engineering Dept., Isfahan University of Medical Sciences, Isfahan, Iran
2Medical Physics Dept., Research Centre and Department of Medical Physics, Mashhad University of Medical Sciences, Mashhad, Iran
3Pharmaceutics Dept., Pharmaceutical Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
4Chemistry Dept., Ferdowsi University of Mashhad, Mashhad, Iran
5Research Center of Medical Physics, Mashhad University of Medical Sciences, Mashhad, Iran
چکیده
Introduction
When a liquid is irradiated with high-intensity and low-frequency ultrasound, acoustic cavitation occurs and there are some methods to determine and quantify this phenomenon. The existing methods for performing these experiments include sonochemiluminescence (SCL) and chemical dosimetric methods. The particles in a liquid decrease the ultrasonic intensity threshold needed for cavitation onset. In this study, a new nanoconjugate made up of Protoporphyrin IX (PpIX) and gold nanoparticles (GNP), i.e., Au-PpIX was used to provide nucleation sites for cavitation. The nonradiative relaxation time of PpIX in the presence of GNPs is longer than the similar time for PpIX without GNPs. This effect can be used in medical diagnostic and therapeutic applications.
Materials and Methods
The acoustic cavitation activity was investigated studying integrated SCL signal in the wavelength range of 400-500 nm in polyacrylamide gel phantom containing luminol using a cooled CCD spectrometer at different intensities of 1 MHz ultrasound. In order to confirm these results, a chemical dosimetric method was utilized, too.
Results
SCL signal level in gel phantom containing Au-PpIX was higher than the other phantoms. These results have been confirmed by the chemical dosimetric data.
Conclusion
This finding can be related to the existence of PpIX as a sensitizer and GNPs as cavitation nuclei. In other words, nanoparticles have acted as the sites for cavitation and have increased the cavitation rate. Another theory is that activation of PpIX has produced more free radicals and has enhanced the SCL signal level.
کلیدواژه‌ها
Cavitation؛ Gold Nanoparticles؛ Polyacrylamide Gel؛ Protoporphyrin IX؛ Sonochemiluminescence؛ Terephthalic Acid
مراجع
  1. Hodnett M, Zequiri B. A detector for monitoring the onset of cavitation during therapy-level measurements of ultrasonic power. J phys Conf Ser. 1. 2004;1(1):112-7.
  2. Tang H, Wang CC, Blankschtein D, Langer R. An investigation of the role of cavitation in low-frequency ultrasound-mediated transdermal drug transport. Pharm Res. 2002;19(8):1160-9.
  3. Marmottant P, Hilgenfeldt S. Controlled vesicle deformation and lysis by single oscillating bubbles. Nature. 2003;423(6936):153-6.
  4. McMurray HN, Wilsom BP. Mechanistic and spatial study of ultrasonically induced luminal chemiluminescence, J Phys Chem. 1999;103(20):3955-62.
  5. Hasanzadeh H, Mokhtari-Dizaji M, Bathaie SZ, Hassan ZM. Evaluation of correlation between chemical dosimetry and subharmonic spectrum analysis to examine the acoustic cavitation. Ultrason Sonochem. 2010;17(5):863-9.
  6. Daniels S, Price DJ. Sonoluminescence in water and agar gels during irradiation with 0.75 MHz continues-wave ultrasound. Ultrasound Med Biol. 1991;17(3):297-308.
  7. Farney CH, Wu T, Holt G, Murray TW, Roy RA. Nucleating cavitation from laser-illuminated nano-particles, Acoust Res Lett. 2005;6(3):138-43.
  8. Barati AH, Mokhtari M, Mozdarani H, Bathaei H, Hassan ZM. Free hydroxyl radical dosimetry by using 1 MHz low level ultrasound waves. Iran J Radiat Res. 2006;3(4):163-9.
  9. Haosheng C, Jiadao W, Darong C. Cavitation damages on solid surfaces in suspensions containing spherical and irregular microparticles. Wear. 2009;266(1-2):345-8.
  10. Tuziuti T, Yasui K, Sivakumar M, Iida Y, Miyoshi N. Correlation between cavitation noise and yield enhancement of sonochemical reaction by particle addition. J Phys Chem A. 2005;109(21):4869-72.
  11. Huang X, Jain PK, El-Sayed IH, El-Sayed MA. Plasmonic photothermal therapy (PPTT) using gold nanopaticles. Lasers Med Sci. 2008;23(3):217-28.
  12. Paciotti GF, Myer L, Weinreich D, Goia D, Pavel N, McLaughlin RE, et al. Colloidal gold: a novel nanoparticles vector for tumor directed drug delivery. Drug Deliv. 2004;11(3):169-83.
  13. Kah JC, Olivo MC, Lee CG, Sheppard CJ. Molecular contrast of EGFR expression using gold nanopaticles as a reflectance-based imaging probe. Mol Cell Probes. 2008;22(1):14-23.
  14. Liu Q, Wang X, Wang P, Xiao L, Hao Q. Comparison between sonodynamic effect with protoporphyrin IX and hematoporphyrin on sarcoma 180. Cancer Chemother Pharmacol. 2007;60(5):671-80.
  15. Li B, Moriyama EH, Li F, Jarvi MT, Allen C, Wilson BC. Diblock copolymer micelles deliver hydrophobic protoporphyrin IX for photodynamic therapy. Photochem Photobiol. 2007;83(6):1505-12.
  16. Jimenez Perez JL, Orea AC, Gallegos ER, Fuentes RG. Photoacoustic Spectroscopy to determine in Vitro the non radiative relaxation time of porotoporphyrin IX solution containing gold metallic nanoparticles. Eur  Phys  J Spec Top. 2008;153(1): 353-6.
  17. Eshghi H, Attaran N, Sazgarnia A, Mirzaie N, Shanei A. Synthesis and Characterization of New Designed Protoporphyrin-Stabillized Gold Nanoparticles for Cancer Cells Nanotechnology-Based Targeting. Int J Nanotechnol. 2011;8(8-9):700-11.
  18. Khokhlova VA, Bailey MR, Reed JA, Cunitz BW, Kaczkowski PJ, Crum LA. Effects of nonlinear propagation, cavitation and boiling in lesion formation by high intensity focused ultrasound in a gel phantom. J Acoust Soc Am. 2006;119(3):1834-48.
  19. Kuroki M, Hachimine K, Abe H, Shibaguchi H, Kuroki M, Maekawa S, et al. Sonodynamic therapy of cancer using novel sonosensitizers. Anticancer Res. 2007;27(6A):3673-7.
  20. Jin ZH, Miyoshi N, Ishiguro K, Umemura S, Kawabata K, Yumita N, et al. Combination effect of photodynamic and sonodynamic therapy on experimental skin squamous cell carcinoma in C3H/HeN mice. J Dermatol. 2000;27(5):294-306.
  21. Clement GT. Perspectives in clinical uses of high intensity focused ultrasound. Ultrasonics. 2004;42(10):1087-93.
 

آمار
تعداد مشاهده مقاله: 2,677
تعداد دریافت فایل اصل مقاله: 1,622